InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Hopman Mark. Director active across 1 company, notably Beta Bionics, Inc.. Aggregated, 2 reports have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €58k. History available since 27 February 2025. The latest transaction was disclosed on 2 June 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations